CONSTISTOP

This brand name is authorized in Nigeria.

Active ingredients

The drug CONSTISTOP contains one active pharmaceutical ingredient (API):

1	Lactulose UNII 9U7D5QH5AE - LACTULOSE
	Lactulose is a synthetic disaccharide which is metabolised by gastro-intestinal bacterial flora to low molecular weight acids (chiefly lactic and acetic acids). There is no endogenous metabolising enzyme in the human gut. Its mode of action in constipation is as an osmotic agent producing soft stools.
	Read more about Lactulose

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-7376	Solution	CONSTISTOP SOLUTION SOL 10 mg 1300ml	97 RNW-PP-270698 CONSTISTOP SOLUTION LACTULOSE SOLUTION USP 10GM/15ML Each 15ml contains Lactulose Concentrate USP equ. to Lactulose 10gm, Colour: Caramel, Aqueous flavored base and Excipents. B4-7376 Drugs ALIMENTARY TRACT AND METABOLISM Imported Products 1300ml POM 1 6/27/2022 CHEZ RESOURCES PHARMACEUTICAL LIMITED, 7 CALABAR STREET FEGGE ONITSHA ANAMBRA 46485780 chezrespharm@gmail.com BHARAT PARENTERALS LTD, VILL. HARIPURA,TA. SAVIL DIST. VADODARA '391 520.' GUJURAT, INDIA, India	28/03/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A06AD11	Lactulose	A Alimentary tract and metabolism → A06 Laxatives → A06A Laxatives → A06AD Osmotically acting laxatives
Discover more medicines within A06AD11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-7376